What is NDC 68001-111?

68001-111 is the product NDC for Lansoprazole, Lansoprazole 15 mg/1 capsule, delayed release, listed with the FDA by BluePoint Laboratories. It has 2 package NDCs, shown above in 10- and 11-digit form.

BluePoint Laboratories, NDC labeler code 68001. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lansoprazole?

94 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lansoprazole NDC 68001-111 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68001-111Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68001-0111Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68001-111-04	6800101110468001011104	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68001-111-04)Marketed from Dec 1, 2013
68001-111-05	6800101110568001011105	90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68001-111-05)Marketed from Dec 1, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lansoprazole
Generic name (nonproprietary): lansoprazole
Active ingredients: Lansoprazole — 15 mg/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: BluePoint LaboratoriesNDC labeler code 68001
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091269
Marketing start: Dec 1, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Inhibition Gastric Acid Secretion (Physiologic effect)Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 68001-111_e1e35404-0cf3-e40d-e053-2995a90a3829SPL ID e1e35404-0cf3-e40d-e053-2995a90a3829SPL set ID 924c5a35-4804-4e14-a2fc-2b84d186d257RxCUI 311277, 596843UNII 0K5C5T2QPGUPC 0368001111058, 0368001112048
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468001011104 followed by a unit qualifier and the quantity

Package 68001-0111-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 20, 2022.

Indications (excerpt from the label)

Lansoprazole delayed-release capsule is a proton pump inhibitor (PPIs) indicated for the: Treatment of active duodenal ulcer in adults. ( 1.1 ) Eradication of H. pylori to reduce the risk of duodenal ulcer recurrence in adults. (1.2) Maintenance of healed duodenal ulcers in adults. ( 1.3) Treatment of active benign gastric ulcer in adults. (1.4) Healing of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults. ( 1.5 ) Risk reduction of NSAID-associated gastric ulcer in adults. (1.6) Treatment of symptomatic gastroesophageal reflux disease ( GERD) in adults and pediatric patients 1 year of age and older. ( 1.7 ) Treatment of erosive esophagitis (EE) in adults and ped…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68001-111

What is NDC 68001-111?: 68001-111 is the product NDC for Lansoprazole, Lansoprazole 15 mg/1 capsule, delayed release, listed with the FDA by BluePoint Laboratories. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lansoprazole.
What is the active ingredient?: Lansoprazole.
Who is the labeler?: BluePoint Laboratories, NDC labeler code 68001. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lansoprazole?: 94 other product NDCs are listed under this name. See all Lansoprazole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lansoprazole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lansoprazole	Lansoprazole 30 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Cardinal Health 107, LLC	55154-8340	55154-8340-00
Lansoprazole	Lansoprazole 15 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Amazon.com Services LLC	72288-672	72288-0672-55
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed release pelletsOral	Preferred Pharmaceuticals Inc.	68788-4141	68788-4141-0368788-4141-0668788-4141-09
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Amazon.com Services LLC	72288-827	72288-0827-03
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed release pelletsOral	Safecor Health LLC	48433-051	48433-0051-08
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Medcore LLC	82461-713	82461-0713-30
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Macleods Pharmaceuticals Limited	33342-311	33342-0311-07
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Macleods Pharmaceuticals Limited	33342-310	33342-0310-07
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Preferred Pharmaceuticals Inc.	68788-8621	68788-8621-0168788-8621-0368788-8621-06+2 more
Lansoprazole	Lansoprazole 15 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	NorthStar Rx LLC	72603-313	72603-0313-10

All 95 Lansoprazole NDCs

Other NDCs under ANDA 091269

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091269
Product	Strength	Form · route	Labeler	Product NDC
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Redpharm Drug	67296-2270
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Dr.Reddy's Laboratories Ltd.	55111-398
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Dr.Reddy's Laboratories Ltd.	55111-399
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Bryant Ranch Prepack	71335-2957
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Proficient Rx LP	63187-510
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Bryant Ranch Prepack	71335-0058
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Major Pharmaceuticals	0904-6662
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Preferred Pharmaceuticals Inc.	68788-6390
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-4456
Lansoprazole DRlansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0148
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	A-S Medication Solutions	50090-6830
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	American Health Packaging	60687-111
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	American Health Packaging	60687-123
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-3687
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	BluePoint Laboratories	68001-112